Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile study

Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile study

BackgroundAnti-CD20 monoclonal antibodies are a class of immunosuppressive drugs widely used in the treatment of central nervous system (CNS) inflammatory diseases, with well-established efficacy and safety. Although rare, these therapies can be associated with serious adverse events including hemat...

Full description

Saved in:
Bibliographic Details
Main Authors: André Aires Fernandes, Ana Lídia Neves, Daniela Ferro, Mafalda Seabra, Teresa Mendonça, Ricardo Soares dos Reis, Maria José Sá, Joana Guimarães, Pedro Abreu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Neurology
Subjects:
central nervous system
multiple sclerosis
anti-CD20 therapies
real-world data
hypogammaglobulinemia
lymphopenia
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1500763/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2024.1500763/full

Similar Items